Loading…

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Saved in:
Bibliographic Details
Published in:Blood 2024-11, Vol.144 (Supplement 1), p.4822-4822
Main Authors: Sheng, Lingshuang, Yan, Zixun, Wang, Li, Wu, Wen, Zhang, Yilun, Shen, Rong, Cao, Weiguo, Li, Lei, Chen, Sheng, Jiang, Xufeng, Yi, Hongmei, Song, Qi, Cheng, Shu, Xu, Pengpeng, Yang, Xuanming, Zhu, Yuxiang, Xu, Xikang, Wang, Fuzhe, Li, Jianyong, Zhao, Wei Li
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2024-198296